Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,5-dihydro-8-hydroxy-5-deazaflavin + NADP+
8-hydroxy-5-deazaflavin + NADPH + H+
5'-O-methyl-7,8-didemethyl-8-hydroxyflavin + NADPH + H+
8-hydroxypyrimido[4,5-b]-2,4-(3H,10H)-dione + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
r
5-deaza-8-hydroxy-10-methylisoalloxazine + NADPH + H+
? + NADP+
5-deaza-8-hydroxyisoalloxazine + NADPH + H+
8-hydroxypyrimido[4,5-b]-2,4-(3H,10H)-dione + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
7,8-didemethyl-8-hydroxy-5-deazariboflavin 5'-phosphate + NADPH + H+
1-deoxy-1-(8-hydroxy-2,4-dioxo-1,3,4,5-tetrahydropyrimido[4,5-b]quinolin-10(2H)-yl)-5-O-phospho-D-ribitol + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
reduced coenzyme F420 + 1-aminoethylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-benzyl-3-acetylpyridine
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-benzylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-ethylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-hydroxyethylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-hydroxypropylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + 1-propylnicotinamide
oxidized coenzyme F420 + ?
Substrates: -
Products: -
?
reduced coenzyme F420 + NADP+
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
additional information
?
-
1,5-dihydro-8-hydroxy-5-deazaflavin + NADP+
8-hydroxy-5-deazaflavin + NADPH + H+
-
Substrates: the kcat value of the forward reaction is 24 times greater than that of the reverse reaction, thus the production of NADPH at pH 7.0 is more favorable than its consumption
Products: -
r
1,5-dihydro-8-hydroxy-5-deazaflavin + NADP+
8-hydroxy-5-deazaflavin + NADPH + H+
-
Substrates: the kcat value of the forward reaction is 24 times greater than that of the reverse reaction, thus the production of NADPH at pH 7.0 is more favorable than its consumption
Products: -
r
5-deaza-8-hydroxy-10-methylisoalloxazine + NADPH + H+
? + NADP+
-
Substrates: -
Products: -
?
5-deaza-8-hydroxy-10-methylisoalloxazine + NADPH + H+
? + NADP+
-
Substrates: -
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
-
Substrates: i.e. 7,8-didemethyl-8-hydroxy-5-deazariboflavin. The enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
-
Substrates: i.e. 7,8-didemethyl-8-hydroxy-5-deazariboflavin. The enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
-
Substrates: i.e. 7,8-didemethyl-8-hydroxy-5-deazariboflavin. The enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
-
Substrates: i.e. 7,8-didemethyl-8-hydroxy-5-deazariboflavin. The enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F0 + NADPH + H+
reduced coenzyme F0 + NADP+
-
Substrates: i.e. 7,8-didemethyl-8-hydroxy-5-deazariboflavin. The enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate
Products: -
?
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate. No activity with NAD+
Products: -
?
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate. No activity with NAD+
Products: -
?
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the main function of this oxidoreductase is probably to provide cells with reduced 8-hydroxy-5-deazaflavin to be used in specific reduction reactions
Products: -
?
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate. No activity with NAD+
Products: -
r
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate. No activity with NAD+
Products: -
?
coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
-
Substrates: the enzyme has an absolute requirement for both the 5-deazaflavin structure and the presence of an 8-hydroxy group in the substrate. No activity with NAD+
Products: -
?
oxidized coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
Substrates: -
Products: -
?
oxidized coenzyme F420 + NADPH + H+
reduced coenzyme F420 + NADP+
Substrates: -
Products: -
?
reduced coenzyme F420 + NADP+
coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
?
reduced coenzyme F420 + NADP+
coenzyme F420 + NADPH + H+
-
Substrates: direct hydride transfer process, A side-specific, with respect to the prochiral center C5 of the dihydro-8-hydroxy-5-deazaflavin cofactor
Products: -
?
reduced coenzyme F420 + NADP+
coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: of the two substrates NADP+ has to bind first, the binding being associated with an induced fit. The stereochemical analysis of the hydrode transfer leads to the conclusion that the observed orientation of the Si-face of coenzyme F420 towards the Si-face of NADP+ allows only the transfer of the proS hydrogen at C5 to the proS position at C4 and vice versa
Products: -
?
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: the enzyme is Si face specific with respect to C5 of reduced coenzyme F420 and Si face specific with respect to C4 of NADP+. The enzyme is specific for both coenzyme F420 and NADP+/NADPH
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
-
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: the enzyme exhibits a sequential kinetic mechanism
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: the enzyme exhibits a sequential kinetic mechanism
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: -
Products: -
r
reduced coenzyme F420 + NADP+
oxidized coenzyme F420 + NADPH + H+
Substrates: FNO catalyzes the NADP+ reduction more efficiently compared to NADPH oxidation
Products: -
r
additional information
?
-
-
Substrates: F420 and the F420 redox moiety, FO, are phenolic 5-deazaflavin cofactors that complement nicotinamide and flavin redox coenzymes in biochemical oxidoreductases and photocatalytic systems. Specifically, these 5-deazaflavins lack the single electron reactivity with O2 of riboflavin-derived coenzymes (FMN and FAD), and, in general, have a more negative redox potential than NAD(P)+. A convenient synthesis of FO is achieved by improving the redox stability of synthetic intermediates containing a polar, electron-rich aminophenol fragment, Fno enzyme activity is restored with FO in the absence of F420, method optimization, overview
Products: -
?
additional information
?
-
Substrates: effects of side chain length of residue Il135 on the donor-acceptor distance between NADP+ and the F420 precursor, FO, overview
Products: -
?
additional information
?
-
Substrates: NADP+ binding site structure, overview. A F420-dependent enzyme
Products: -
?
additional information
?
-
-
Substrates: NADP+ binding site structure, overview. A F420-dependent enzyme
Products: -
?
additional information
?
-
Substrates: no activity of wild-type and mutants with 1-benzylnicotinic acid
Products: -
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0028
1,5-dihydro-8-hydroxy-5-deazaflavin
-
pH 7.0, 20°C
2 - 18
1-aminoethylnicotinamide
-
7.4
1-benzyl-3-acetylpyridine
wild-type enzyme, pH 8.0, 25°C
-
4.3 - 9.5
1-benzylnicotinamide
-
25
1-ethylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
2 - 33
1-hydroxyethylnicotinamide
-
25 - 35
1-hydroxypropylnicotinamide
-
5.7 - 35
1-propylnicotinamide
-
0.0135
5'-O-methyl-7,8-didemethyl-8-hydroxyflavin
-
pH 6.0, 22°C
0.0193
5-deaza-8-hydroxyisoalloxazine
-
pH 6.0, 22°C
0.0155
7,8-didemethyl-8-hydroxy-5-deazariboflavin 5'-phosphate
-
pH 6.0, 22°C
0.008
8-hydroxy-5-deazaflavin
-
pH 7.0, 20°C
0.0775
8-hydroxypyrimido[4,5-b]-2,4-(3H,10H)-dione
-
pH 6.0, 22°C
0.0057
coenzyme F0
-
pH 6.0, 22°C
0.0034 - 0.0625
coenzyme F420
0.0036 - 4
oxidized coenzyme F420
0.0077 - 0.15
reduced coenzyme F420
additional information
additional information
-
2 - 3
1-aminoethylnicotinamide
enzyme mutant G29Y, pH 8.0, 25°C
-
12
1-aminoethylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
14
1-aminoethylnicotinamide
enzyme mutant P98H, pH 8.0, 25°C
-
18
1-aminoethylnicotinamide
enzyme mutant G29S, pH 8.0, 25°C
-
4.3
1-benzylnicotinamide
enzyme mutant G29W, pH 8.0, 25°C
-
6.4
1-benzylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
9.5
1-benzylnicotinamide
enzyme mutant G29Y, pH 8.0, 25°C
-
2 - 3
1-hydroxyethylnicotinamide
enzyme mutant G29Y, pH 8.0, 25°C
-
20
1-hydroxyethylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
20
1-hydroxyethylnicotinamide
enzyme mutant P98H, pH 8.0, 25°C
-
33
1-hydroxyethylnicotinamide
enzyme mutant P98Y, pH 8.0, 25°C
-
25
1-hydroxypropylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
35
1-hydroxypropylnicotinamide
enzyme mutant P89Y, pH 8.0, 25°C
-
5.7
1-propylnicotinamide
enzyme mutant P89H, pH 8.0, 25°C
-
10
1-propylnicotinamide
wild-type enzyme, pH 8.0, 25°C
-
18
1-propylnicotinamide
enzyme mutant G29L, pH 8.0, 25°C
-
27
1-propylnicotinamide
enzyme mutant P89L, pH 8.0, 25°C
-
35
1-propylnicotinamide
enzyme mutant P89Y, pH 8.0, 25°C
-
0.0034
coenzyme F420
-
pH 6.0, 22°C
0.0625
coenzyme F420
-
pH and temperature not specified in the publication
0.0137
NADP+
-
pH 7.0, 20°C
0.0144
NADP+
-
pH 6.0, 22°C
0.07
NADP+
pH 8.0, temperature not specified in the publication
0.37
NADP+
-
pH and temperature not specified in the publication
0.00027
NADPH
phase I, pH 6.5, 22°C, recombinant mutant I135A
0.0007
NADPH
phase I, pH 6.5, 22°C, recombinant mutant I135V
0.0023
NADPH
phase I, pH 6.5, 22°C, recombinant wild-type enzyme
0.0029
NADPH
phase II, pH 6.5, 22°C, recombinant mutant I135A
0.0104
NADPH
-
pH 7.0, 20°C
0.016
NADPH
phase I, pH 6.5, 22°C, recombinant mutant I135G
0.0195
NADPH
-
pH 6.0, 22°C
0.05
NADPH
pH 6.0, temperature not specified in the publication
0.051
NADPH
phase II, pH 6.5, 22°C, recombinant mutant I135V
0.062
NADPH
phase II, pH 6.5, 22°C, recombinant wild-type enzyme
0.142
NADPH
-
pH and temperature not specified in the publication
0.654
NADPH
phase II, pH 6.5, 22°C, recombinant mutant I135G
3.2
NADPH
pH 6.0, 25°C, recombinant mutant S50E
4.4
NADPH
pH 6.0, 25°C, recombinant mutant R55S
5
NADPH
pH 6.0, 25°C, recombinant mutant T28A
5.4
NADPH
pH 6.0, 25°C, recombinant mutant T28A/R55A
6.3
NADPH
pH 6.0, 25°C, recombinant mutant R55N
6.5
NADPH
pH 6.0, 25°C, recombinant mutant R51E/R55N
7
NADPH
pH 6.0, 25°C, recombinant mutant R55A
7.3
NADPH
pH 6.0, 25°C, recombinant wild-type enzyme
8.2
NADPH
pH 6.0, 25°C, recombinant mutant S50Q
8.6
NADPH
pH 6.0, 25°C, recombinant mutant R51A
8.7
NADPH
pH 6.0, 25°C, recombinant mutant R51V
9.6
NADPH
pH 6.0, 25°C, recombinant mutant R55V
9.8
NADPH
pH 6.0, 25°C, recombinant mutant S50E/R55V
10
NADPH
pH 6.0, 25°C, recombinant mutant R51E/R55A
10
NADPH
pH 6.0, 25°C, recombinant mutant R51V/R55V
12
NADPH
pH 6.0, 25°C, recombinant mutant T28A/R51V
12
NADPH
pH 6.0, 25°C, recombinant mutant T28A/R51V/R55V
14
NADPH
pH 6.0, 25°C, recombinant wild-type enzyme
19
NADPH
pH 6.0, 25°C, recombinant mutant T28A
20
NADPH
pH 6.0, 25°C, recombinant mutant S50E/R55A
29
NADPH
pH 6.0, 25°C, recombinant mutant R55A
32
NADPH
pH 6.0, 25°C, recombinant mutant R51E/R55S
49
NADPH
pH 6.0, 25°C, recombinant mutant R55V
61.6
NADPH
pH 6.5, 22°C, recombinant enzyme
93
NADPH
pH 6.0, 25°C, recombinant mutant T28A/R55A
170
NADPH
pH 6.0, 25°C, recombinant mutant R55S
180
NADPH
above, pH 6.0, 25°C, recombinant mutant R51A
180
NADPH
above, pH 6.0, 25°C, recombinant mutant R51V
500
NADPH
above, pH 6.0, 25°C, recombinant mutant R51E/R55A
500
NADPH
above, pH 6.0, 25°C, recombinant mutant R51E/R55N
500
NADPH
above, pH 6.0, 25°C, recombinant mutant R51E/R55S
500
NADPH
above, pH 6.0, 25°C, recombinant mutant R51V/R55V
500
NADPH
above, pH 6.0, 25°C, recombinant mutant R55N
500
NADPH
above, pH 6.0, 25°C, recombinant mutant S50E
500
NADPH
above, pH 6.0, 25°C, recombinant mutant S50E/R55A
500
NADPH
above, pH 6.0, 25°C, recombinant mutant S50E/R55V
500
NADPH
above, pH 6.0, 25°C, recombinant mutant S50Q
500
NADPH
above, pH 6.0, 25°C, recombinant mutant T28A/R51V
500
NADPH
above, pH 6.0, 25°C, recombinant mutant T28A/R51V/R55V
0.0036
oxidized coenzyme F420
with F420 precursor, FO, pH 6.5, 22°C, recombinant mutant I135A
0.0036
oxidized coenzyme F420
with F420 precursor, FO, pH 6.5, 22°C, recombinant mutant I135G
0.0037
oxidized coenzyme F420
with F420 precursor, FO, pH 6.5, 22°C, recombinant mutant I135V
0.004
oxidized coenzyme F420
with F420 precursor, FO, pH 6.5, 22°C, recombinant wild-type enzyme
0.01
oxidized coenzyme F420
pH 5.5, 65°C
0.1
oxidized coenzyme F420
pH 6.0, 30°C
0.3
oxidized coenzyme F420
pH 6.0, temperature not specified in the publication
2
oxidized coenzyme F420
pH 6.0, 25°C, recombinant enzyme
4
oxidized coenzyme F420
pH 6.5, 22°C, recombinant enzyme
0.0077
reduced coenzyme F420
-
pH and temperature not specified in the publication
0.0129
reduced coenzyme F420
-
pH 6.0, 22°C
0.02
reduced coenzyme F420
pH 8.0, 65°C
0.04
reduced coenzyme F420
pH 8.0, 30°C
0.15
reduced coenzyme F420
pH 8.0, temperature not specified in the publication
additional information
additional information
steady-state kinetics
-
additional information
additional information
-
steady-state kinetics
-
additional information
additional information
-
analysis of the F420 redox moiety (FO)-dependent NADP+/NADPH redox process by stopped-flow spectrophotometry, steady state kinetics, overview
-
additional information
additional information
substrate binding studies, steady-state and pre steady-state kinetic analysis with wild-type enzyme Fno and Ile135 Fno mutant variants, I135A, I135V, and I135G, overview. Steady-state kinetic analysis of wild-type Fno and the variants show classical Michaelis-Menten kinetics with varying FO concentrations. The data reveal a decreased kcat as side chain length decreased, with varying FO concentrations. The steady-state plots reveal non-Michaelis-Menten kinetic behavior when NADPH is varied. The double reciprocal plot of the varying NADPH concentrations displays a downward concave shape, while the NADPH binding curves gave Hill coefficients of less than 1. These data suggest that negative cooperativity occurs between the two identical monomers. The pre steady-state Abs420 versus time trace reveals biphasic kinetics, with a fast phase (hydride transfer) and a slow phase. The fast phase displays an increased rate constant as side chain length decreases. The rate constant for the second phase, remained about 2/s for each variant. Pre-steady-state data with F420 cofactor and NADPH for the enzyme Fno mutant variants reveal biphasic kinetics with a fast and slow phase, similar with wild-type Fno, overview
-
additional information
additional information
the enzyme shows half-site reactivity and negative cooperativity (Koshland-Nemethy-Filmer model) in the reversible reduction of NADP+ through the transfer of a hydride from the reduced F420 cofactor, steady-state kinetic analysis revealing classical Michaelis-Menten kinetics with varying concentrations of the F420 redox moiety, and non-Michaelis-Menten kinetic behavior when NADPH is varied. Pre-steady-state, stopped flow, Single-turnover, and steady-state kinetics, detailed overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.